Fol. Biol. 2007, 53, 66-68
https://doi.org/10.14712/fb2007053020066
Collagen Degradation Products and Proinfiammatory Cytokines in Systemic and Localized Scleroderma
Crossref Cited-by Linking
- Hettema M. E., Bootsma H., Graaff R., de Vries R., Kallenberg C. G. M., Smit A. J.: Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis. International Journal of Rheumatology 2011, 2011, 1. <https://doi.org/10.1155/2011/417813>
- Chabaud Stéphane, Moulin Véronique J.: Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis. International Journal of Rheumatology 2011, 2011, 1. <https://doi.org/10.1155/2011/495792>
- Busquets J., Del Galdo F., Kissin E. Y., Jimenez S. A.: Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?. Rheumatology 2010, 49, 1069. <https://doi.org/10.1093/rheumatology/keq024>
- Castro Susan V, Jimenez Sergio A: Biomarkers in Systemic Sclerosis. Biomarkers Med. 2010, 4, 133. <https://doi.org/10.2217/bmm.09.79>
- Hettema M. E., Zhang D., Stienstra Y., Oomen P. N. H., Smit A. J., Kallenberg C. G. M., Bootsma H.: Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle. Rheumatology 2008, 47, 1409. <https://doi.org/10.1093/rheumatology/ken248>